Identification and characterization of two chloramphenicol glucuronides from the in vitro glucuronidation of chloramphenicol in human liver microsomes

被引:17
|
作者
Chen, M.
Howe, D.
Leduc, B.
Kerr, S.
Williams, D. A.
机构
[1] CombinatoRx Inc, Dept Preclin Dev & Formulat, Cambridge, MA 02142 USA
[2] Massachusetts Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Boston, MA USA
[3] Vertex Pharmaceut Inc, Drug Innovat Pharmacokinet Dept, Cambridge, MA USA
关键词
chloramphenicol; human liver microsomes; glucuronidation; enzyme kinetics; chloramphenicol O-glucuronides; liquid chromatography coupled with tandem mass spectrometry detection (LC-MS/MS); DRUG-METABOLISM; TOXICITY; DISPOSITION; MODEL;
D O I
10.1080/00498250701620734
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study reports the development of a specific and sensitive liquid chromatography coupled with tandem mass spectrometry detection (LC-MS/MS) assay for the quantification of the in vitro O-glucuronidation of chloramphenicol (Cl?), the determination of the kinetic parameters for the O-glucuronidation of CP in pooled human liver microsomes (HLM), the biosynthesis of the CP glucuronides (CPGlu), and identification of the structures of CPGlu by H-1-nuclear magnetic resonance (NMR) and MS. Two glucuronyl derived metabolites of CP were obtained from the incubation of alamethicin-activated HLM with CP and uridine 5'-diphosphoglucuronic acid (UDPGA) in pH 7.4 TRIS buffer. Their identification and structural confirmation were achieved by beta-glucuronidase hydrolysis, in the presence and absence of UDPGA, and by H-1-NMR and LC-MS/ MS. These two metabolites were biosynthesized, isolated, and purified using high-performance liquid chromatography (HPLC). Their structures were further identified as the 1-O-CPGlu (the minor glucuronide formed at the secondary alcohol of CP) and 3-O-CPGlu (the major glucuronide formed at the primary alcohol of CP) by LC-MS/MS and two-dimensional NMR. The enzymatic kinetic parameters K-m and V-max in HLM for the 3-O-CPGlu were determined to be 650 mu M and 0.26 nmoles min(-1) mg(-1), respectively, and for the 1-O-CPGlu to be 301 mu M and 0.014 nmoles min(-1) mg(-1), respectively. This study also provides a sensitive and specific method for the measurement of in vitro CP-UDP-glucuronosyltransferase (UGT) activity.
引用
收藏
页码:954 / 971
页数:18
相关论文
共 50 条
  • [31] THE NITROREDUCTION OF CHLORAMPHENICOL BY HUMAN-LIVER TISSUE
    SALEM, Z
    MURRAY, T
    YUNIS, AA
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1981, 97 (06): : 881 - 886
  • [32] IN VITRO ACTION OF CHLORAMPHENICOL AND CHLORAMPHENICOL-ANALOGUES ON METABOLISM OF HUMAN IMMATURE RED BLOOD CELLS
    ERSLEV, AJ
    IOSSIFIDES, IA
    ACTA HAEMATOLOGICA, 1962, 28 (01) : 1 - &
  • [33] IN VITRO GLUCURONIDATION OF trans-PICEID AND trans-PICEATANNOL BY HUMAN LIVER MICROSOMES
    Henry-Vitrac, Caroline
    Richard, T.
    Desmouliere, A.
    Monti, J. -P.
    Merillon, J. -M.
    Krisa, S.
    JOURNAL INTERNATIONAL DES SCIENCES DE LA VIGNE ET DU VIN, 2008, 42 (04): : 241 - 243
  • [34] In vitro glucuronidation of thyroxine and triiodothyronine by liver Microsomes and recombinant human UDP-Glucuronosyltransferases
    Tong, Zeen
    Li, Hongshan
    Goljer, Igor
    McConnell, Oliver
    Chandrasekaran, Appavu
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (12) : 2203 - 2210
  • [35] In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin
    Fisher, MB
    Campanale, K
    Ackermann, BL
    Vandenbranden, M
    Wrighton, SA
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (05) : 560 - 566
  • [36] In vitro glucuronidation of flavopiridol (NSC649890) (FLAVO) by human liver microsomes.
    Ramírez, J
    Iyer, L
    Lush, RM
    Mortell, M
    Feuer, JA
    Figg, WD
    Sausville, EA
    Ratain, MJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 149 - 149
  • [37] RAPID GLUCURONIDATION OF TRIIODOTHYROACETIC AND TETRAIODOTHYROACETIC ACID TO ESTER GLUCURONIDES IN HUMAN LIVER AND TO ETHER GLUCURONIDES IN RAT-LIVER
    MORENO, M
    KAPTEIN, E
    GOGLIA, F
    VISSER, TJ
    ENDOCRINOLOGY, 1994, 135 (03) : 1004 - 1009
  • [38] Glucuronidation of dihydrocodeine by human liver microsomes and the effect of inhibitors
    Kirkwood, LC
    Nation, RL
    Somogyi, AA
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (3-4) : 266 - 270
  • [39] A NEW PATHWAY FOR THE OXIDATIVE-METABOLISM OF CHLORAMPHENICOL BY RAT-LIVER MICROSOMES
    MORRIS, PL
    BURKE, TR
    GEORGE, JW
    POHL, LR
    DRUG METABOLISM AND DISPOSITION, 1982, 10 (05) : 439 - 445
  • [40] Stereoselective Glucuronidation of Carvedilol in Human Liver and Intestinal Microsomes
    Hanioka, Nobumitsu
    Tanaka, Sawako
    Moriguchi, Yushi
    Narimatsu, Shizuo
    PHARMACOLOGY, 2012, 90 (3-4) : 117 - 124